For third time since 2020, Stitt orders state fleet downsized. Have those efforts worked?
Long before DOGE-OK was a thing, Gov. Kevin Stitt tried to save Oklahoma money through one persistent quest.
Stitt announced the creation, via executive order, of the Division of Government Efficiency — modeled after a similar agency at the federal level — during his State of the State speech earlier this month. But two weeks earlier, he issued another, less-publicized executive order, saying he's 'dedicating state efforts to further reduce the number of state-owned vehicles in operation.'
It's at least his third effort, since taking office in January 2019, to reduce the number of state-owned vehicles. He issued similar executive orders in 2020 and 2023.
So, why the passion for that particular issue?
'I know the waste and I know the people that have vehicles,' Stitt said in January, a few days after issuing his latest executive order on the subject. 'I see the lots. Just trying to find out how many vehicles we have has been a challenge. … I think we're down 600, 700 vehicles. My goal is to get rid of 1,000 vehicles and just be able to share those vehicles more efficiently, just trying to get the agencies to work together. That's why I like consolidation a little bit, I like sharing some of the resources that we already have in state government.'
Stitt told the story of former Indiana Gov. Mitch Daniels, who governed the Hoosier State from 2005 to 2013. Indiana's state vehicle fleet had grown in size enough that a state agency wanted funding for a new parking garage. Daniels was skeptical that Indiana state government needed so many vehicles.
Daniels, Stitt said, had staffers place a penny on the right back tire of state-owned vehicles in Indianapolis, the state's capital. A few weeks later, they went back to see if the pennies were still on the tires. If they were, the governor ordered those vehicles to be sold. The garage didn't get built.
'I thought, man, that's a brilliant idea,' Stitt said.
Stitt's first order on the subject was issued Feb. 11, 2020. It noted 'it has been brought to my attention that the State of Oklahoma owns perhaps in excess of 9,000' vehicles, 'and it is probable that more than a few are under-utilized and not necessary in order for the State to perform its services to the citizens of the State.'
He ordered the head of every executive agency to report any agency vehicle that had less than 4,800 miles of usage that year. But a month later, the COVID-19 pandemic began raging and Stitt had more pressing issues with which to deal.
Stitt made a second attempt to get a handle on the size of the state fleet in May 2023 with another executive order. That order noted the state 'has reinitiated an aggressive push to downsize the state fleet' and that from Jan. 1 of that year until the order was issued, the state had downsized its fleet by more than 350 vehicles.
That order said for the state to be able to accurately track all of its vehicles, executive agency leaders needed to work with the Office of Management and Enterprise Services to install automatic vehicle locators in all state vehicles.
Stitt's most recent order on the subject came down Jan. 23. It instructs executive agency heads that, by March 31, to provide to OMES information on any vehicle in control of the state agency with less than 15,000 miles of usage in 2023.
'The administrative head of every state agency shall work with the office of Fleet Management in OMES to return all state vehicles with less than 12,000 miles of usage in 2023 to OMES for proper disposition,' the order stated. Exceptions will be made for special-purpose vehicles, such as winter storm salt trucks.
How successful have the governor's efforts to reduce the fleet been? The results seem mixed.
Abegail Cave, a spokeswoman for Stitt, told The Oklahoman that during 2024, state agencies self-reported the use of 11,851 vehicles ― far more than the approximately 9,000 mentioned in his 2020 executive order — with a total accumulated mileage of 40,627,192 miles.
That said, 616 surplus vehicles were sold by the state during 2024, Cave said. So the size of the state fleet was reduced.
Stitt said Wednesday the state now has 1,000 fewer vehicles than when he took office, although a spokesperson for Stitt wasn't immediately able to say how many vehicles the state had when he became governor in 2019, so the governor's claim couldn't be verified.
Stitt criticized those who might think the push for fewer state government vehicles didn't matter in the context of efforts to reduce government spending.
'Don't say it's a small part of the budget,' Stitt said. 'If I can cut 1,000 vehicles, I think most Oklahomans would say, 'Great job, governor — let's cut that.' What may be small to you may not be small to others. I'm going to cut as much as I can.'
This article originally appeared on Oklahoman: Oklahoma Gov. Stitt issues 3rd order on reducing state-owned vehicles
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
an hour ago
- Business Insider
Novavax Stock (NVAX) Gets a Boost from ‘Robust Immune Responses'
Novavax (NVAX) stock jumped on Wednesday after the vaccine maker released results from a Phase 3 clinical trial of its COVID-19-Influenza Combination (CIC) and stand-alone flu vaccine. The initial cohort results from this study included 'robust immune responses' for the CIC and flu vaccine that were comparable to licensed rivals Nuvaxovid and Fluzone HD. Confident Investing Starts Here: Additionally, Novavax noted that the two vaccines were well tolerated. Almost all of the adverse events, greater than 98%, that were experienced by patients were mild or moderate in severity. The trial includes roughly 2,000 patients aged 65 or older. Novavax stated that it will continue to seek partners to further the development of its CIC and stand-alone flu vaccines. The results from this study provide it with the data it needs for discussions with potential partners. NVAX Stock Movement Today While NVAX stock had soared more than 2% in pre-market trading, the company couldn't maintain those gains. As a result, the stock is only up 0.56% as of Wednesday morning. Investors will also note that shares are down 8.83% year-to-date and 54.6% over the past 12 months. The Phase 3 clinical trial data also failed to attract investor interest today. Trading volume was muted at 1.38 million shares, compared to a three-month daily average of roughly 11.29 million units. Is Novavax Stock a Buy, Sell, or Hold? Turning to Wall Street, the analysts' consensus rating for Novavax is Hold, based on one Buy, two Hold, and a single Sell rating over the past three months. With that comes an average NVAX stock price target of $11.25, representing a potential 55.39% upside for the shares. Spark, TipRanks' AI analyst, highlighted 'strong revenue growth and profitability improvements' but warned of 'negative equity and cash flow challenges.'
Yahoo
2 hours ago
- Yahoo
Editorial: Ax to the vax — RFK Jr. continues on his anti-vaccine warpath
It's time for President Donald Trump, despite his own casual relationship with the truth, to stop putting American lives at risk and get rid of his dangerous quack in chief, Health and Human Services Secretary Robert F. Kennedy Jr. In his latest broadside against science, Kennedy is removing all 17 members of the Advisory Committee for Immunization Practices, the CDC's main advisory body, to ostensibly restore 'public trust above any specific pro- or anti-vaccine agenda.' God protect us, as RFK won't. This is how a society becomes undone. Science and reason get stepped on by half-truths and conspiracy theories. Next comes preventable death and disease. The problem is that there is no anti-vaccine side in the legitimate practice of science and medicine. The department's accompanying press release denigrated 'public health ideology' as if the practice of public health wasn't the CDC's only function. Researchers and doctors should be biased in favor of evidence-based therapeutics that save lives. Railing against bias towards vaccines is like a politician condemning researchers biased in favor of seatbelts in cars or keeping lead out of household paint. It's idiotic. We understand that the Make America Healthy Again movement Kennedy leads is all about questioning medical and nutritional practice. On a really abstract level, we are in agreement that no scientific truisms should be entirely above questioning — such a perspective would be anti-science. But there is a specific and long-standing methodology for actually answering those questions, and it is not debate club or who can most incite crowds of followers. It is the scientific method, under which hypotheses can be rigorously tested in ways that are replicable and based on clear and clearly laid out evidence. In that arena — really the only arena that actually matters when it comes to public health — the safety and efficacy of vaccines has been conclusively established. There is no additional discussion necessary or appropriate, particularly when it comes to immunizations that have now been standard-issue for decades and have by all measures radically decreased illness and mortality where they've been successfully deployed. The measles vaccine will always be better for individuals and public health than getting the measles. The same is true for polio, tetanus, COVID and all else. Preying on public skepticism of the pharmaceutical and health industries to hawk alternative approaches that are often unregulated and don't work is damaging it enough. Yet a true believer like RFK is more dangerous, especially now that he stands at the pinnacle of our nation's public health bureaucracy, a position that allows him to substantively impose his own anti-science view on an unsuspecting public and take the choice away from the American people. If RFK's new picks for ACIP — which the secretary falsely promised Sen. Bill Cassidy he wouldn't touch during his confirmation process — step back from recommending various crucial vaccines, this could substantially prevent even those who want to make the informed decision to receive inoculations or have their children vaccinated from being able to do so. As much as Kennedy and his followers emphasize the need for people to be able to make individual choices about their health, they seem hell-bent on taking that choice away entirely, especially given that insurance is not required to cover vaccines that are not CDC-recommended. We wonder what RFK will have to say for himself as once-eradicated diseases begin cutting through the U.S. population again. Is there anything that will get him to veer off this disastrous course? If the answer is no, and we suspect it is, then he must be removed before he can further damage public health. _____


Business Upturn
4 hours ago
- Business Upturn
Covid-19 India Cases 2025 Live Updates: Active cases cross 7,000-mark — not Delhi, West Bengal or Maharashtra but this state has most cases
By Aditya Bhagchandani Published on June 12, 2025, 10:07 IST India has seen a fresh rise in Covid-19 infections with active cases crossing the 7,000 mark as of June 12, 2025. The country now has a total of 7,154 active cases, as per data released by the Ministry of Health and Family Welfare. Importantly, six new Covid-related deaths have been reported in the last 24 hours — two from Maharashtra, one from Madhya Pradesh, and three others under review. Kerala leads the chart as worst-hit state Despite no recent headlines from major metros like Delhi, Kolkata, or Mumbai, it is Kerala that continues to top the active caseload in India with 2,165 active cases, accounting for over 30% of the national burden. Gujarat (1,281), West Bengal (747), Delhi (731), and Maharashtra (615) are also witnessing relatively high numbers. New Omicron variants fuelling mild surges Health experts attribute the recent rise to highly transmissible but less severe Omicron sub-variants such as JN.1, NB.1.8.1, LF.7, and XFC. These strains have been classified by the WHO as 'Variants Under Monitoring,' meaning they are not currently considered dangerous but are being tracked closely. Covid becoming part of seasonal cycles While SARS-CoV-2 has not disappeared, its pattern of recurrence has now become more predictable, similar to influenza. The ongoing infections mostly result in milder symptoms, but vulnerable populations are advised to remain cautious and follow preventive protocols. Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.